tiprankstipranks
Trending News
More News >
Stayble Therapeutics AB (DE:4K4)
FRANKFURT:4K4
Germany Market

Stayble Therapeutics AB (4K4) Income Statement

Compare
1 Followers

Stayble Therapeutics AB Income Statement

Last quarter (Q4 2025), Stayble Therapeutics AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Stayble Therapeutics AB's net income was kr-1.52M. See Stayble Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr -148.21Kkr 0.00kr 0.00kr 0.00
Operating Expenses
kr 6.90Mkr 13.03Mkr 23.95Mkr 24.95Mkr 12.14M
Depreciation and Amortization
kr 0.00kr 148.21Kkr 24.00Mkr 24.95Mkr 12.14M
EBITDA
kr -6.90Mkr -12.22Mkr 309.41Kkr -24.50Mkr -12.03M
Operating Income
kr -6.90Mkr -12.79Mkr -23.95Mkr -24.80Mkr -12.14M
Other Income/Expenses
kr -32.00Kkr 376.00Kkr 217.28Kkr 270.51Kkr 49.52K
Pretax Income
kr -6.93Mkr -12.42Mkr -23.74Mkr -24.53Mkr -12.09M
Net Income
kr -6.93Mkr -12.42Mkr -23.74Mkr -24.53Mkr -12.04M
Per Share Metrics
Basic EPS
kr -0.12kr -0.33kr -0.92kr -1.72kr -0.85
Diluted EPS
kr -0.12kr -0.33kr -0.92kr -1.72kr -0.85
Weighted Average Shares Outstanding
59.06M 37.88M 25.76M 14.23M 14.23M
Weighted Average Shares Outstanding (Diluted)
59.06M 37.88M 25.76M 14.23M 14.23M
Currency in SEK

Stayble Therapeutics AB Earnings and Revenue History